BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6383583)

  • 21. Medical therapy to reduce postoperative Crohn's disease recurrence.
    Achkar JP; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the immune response to aerobic and anaerobic intestinal bacteria in a patient with Crohn's disease.
    Danielsson D; Kjellander J; Persson S; Wallensten S
    Scand J Infect Dis Suppl; 1979; (19):52-60. PubMed ID: 223235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local injection of Infliximab for the treatment of perianal Crohn's disease.
    Poggioli G; Laureti S; Pierangeli F; Rizzello F; Ugolini F; Gionchetti P; Campieri M
    Dis Colon Rectum; 2005 Apr; 48(4):768-74. PubMed ID: 15768185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.
    Balfour Sartor R
    J Clin Gastroenterol; 2007; 41 Suppl 1():S37-43. PubMed ID: 17438417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recurrence of Crohn's disease after surgery--causes and risks].
    Mirow L; Hauenschild L; Hildebrand P; Kleemann M; Keller R; Franke C; Roblick UJ; Bruch HP; Kujath P
    Zentralbl Chir; 2008 Apr; 133(2):182-7. PubMed ID: 18415909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of anorectal complications in Crohn's disease.
    Michelassi F; Melis M; Rubin M; Hurst RD
    Surgery; 2000 Oct; 128(4):597-603. PubMed ID: 11015093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of Crohn's disease treated with infliximab.
    Arslan S; Kav T; Besisik F; Kaymakoglu S; Pinarbasi B; Tözün N; Hamzaoglu HO; Duman D; Ulker A; Parlak E; Palabiyikoglu M; Dökmeci A
    Hepatogastroenterology; 2003; 50(52):952-6. PubMed ID: 12845957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
    Rosén A; Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O
    Gastroenterology; 1982 Sep; 83(3):541-9. PubMed ID: 6124473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and microbiology of abdominal and pelvic abscess in Crohn's disease.
    Keighley MR; Eastwood D; Ambrose NS; Allan RN; Burdon DW
    Gastroenterology; 1982 Dec; 83(6):1271-5. PubMed ID: 7129031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of topical metronidazole in the treatment of anorectal Crohn's disease.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(5):380-3. PubMed ID: 24459783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment.
    Guslandi M; Fanti L; Testoni PA
    Hepatogastroenterology; 2002; 49(47):1296-7. PubMed ID: 12239929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: treatment of perianal fistulizing Crohn's disease.
    Rutgeerts P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():106-10. PubMed ID: 15352905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after ileocecal resection for Crohn's disease.
    Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K; Chen SH
    Am Surg; 1997 Jul; 63(7):627-33. PubMed ID: 9202538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healing of perineal Crohn's disease with metronidazole.
    Bernstein LH; Frank MS; Brandt LJ; Boley SJ
    Gastroenterology; 1980 Aug; 79(2):357-65. PubMed ID: 7399243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
    Fichera A; McCormack R; Rubin MA; Hurst RD; Michelassi F
    Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
    Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
    Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-abdominal and pelvic abscess in Crohn's disease: results of noninvasive and surgical management.
    Jawhari A; Kamm MA; Ong C; Forbes A; Bartram CI; Hawley PR
    Br J Surg; 1998 Mar; 85(3):367-71. PubMed ID: 9529495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.
    Tromm A; Griga T; May B
    Hepatogastroenterology; 1999; 46(30):3124-35. PubMed ID: 10626173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of Crohn's disease with metronidazole -- an uncontrolled trial --.
    Kasper H; Sommer H; Kühn HA
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):217-21. PubMed ID: 573534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.